Shire Sues Watson Again Over Adderall Patents
Shire LLC accused Watson Pharmaceuticals Inc. in New York on Tuesday of infringing its patents for attention deficit hyperactivity disorder drug Adderall XR and violating an earlier licensing agreement with the...To view the full article, register now.
Already a subscriber? Click here to view full article